Bridgeway Capital Management Inc. grew its holdings in shares of Teligent Inc (NASDAQ:TLGT) by 112.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 283,081 shares of the company’s stock after acquiring an additional 150,000 shares during the quarter. Bridgeway Capital Management Inc. owned 0.53% of Teligent worth $1,118,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Virtu Financial LLC purchased a new position in shares of Teligent during the third quarter worth approximately $172,000. BlackRock Inc. raised its stake in shares of Teligent by 0.5% during the third quarter. BlackRock Inc. now owns 3,463,605 shares of the company’s stock worth $13,681,000 after acquiring an additional 16,198 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Teligent by 15.9% during the third quarter. Wells Fargo & Company MN now owns 123,329 shares of the company’s stock worth $488,000 after acquiring an additional 16,919 shares in the last quarter. Northpointe Capital LLC purchased a new position in shares of Teligent during the third quarter worth approximately $2,948,000. Finally, First Light Asset Management LLC raised its stake in shares of Teligent by 4.6% during the second quarter. First Light Asset Management LLC now owns 1,151,032 shares of the company’s stock worth $3,983,000 after acquiring an additional 50,209 shares in the last quarter. 68.05% of the stock is currently owned by hedge funds and other institutional investors.

TLGT stock opened at $1.78 on Friday. The company has a market cap of $99.58 million, a price-to-earnings ratio of -9.26 and a beta of 0.94. Teligent Inc has a one year low of $1.72 and a one year high of $4.52. The company has a current ratio of 2.77, a quick ratio of 1.79 and a debt-to-equity ratio of 3.31.

Teligent (NASDAQ:TLGT) last posted its quarterly earnings results on Tuesday, November 13th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The firm had revenue of $18.29 million for the quarter, compared to the consensus estimate of $19.80 million. Teligent had a negative net margin of 54.17% and a negative return on equity of 43.00%. On average, analysts anticipate that Teligent Inc will post -0.16 EPS for the current year.

Several research firms have commented on TLGT. Canaccord Genuity set a $4.00 price target on shares of Teligent and gave the stock a “hold” rating in a research note on Monday, August 13th. ValuEngine raised shares of Teligent from a “hold” rating to a “buy” rating in a research note on Friday, August 10th.

WARNING: This story was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://theolympiareport.com/2018/12/07/bridgeway-capital-management-inc-boosts-holdings-in-teligent-inc-tlgt.html.

About Teligent

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Featured Article: How is an ETF different from a mutual fund?

Institutional Ownership by Quarter for Teligent (NASDAQ:TLGT)

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.